567 related articles for article (PubMed ID: 25649362)
21. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
[TBL] [Abstract][Full Text] [Related]
22. Incident and long-term HIV-1 infection among pregnant women in Brazil: Transmitted drug resistance and mother-to-child transmission.
Lima YA; Cardoso LP; Reis MN; Stefani MM
J Med Virol; 2016 Nov; 88(11):1936-43. PubMed ID: 27037910
[TBL] [Abstract][Full Text] [Related]
23. Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.
Cavalcanti AM; Lacerda HR; Brito AM; Pereira S; Medeiros D; Oliveira S
Mem Inst Oswaldo Cruz; 2007 Nov; 102(7):785-92. PubMed ID: 17992369
[TBL] [Abstract][Full Text] [Related]
24. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.
Ross LL; Shortino D; Shaefer MS
AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
[TBL] [Abstract][Full Text] [Related]
26. Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba.
Pérez L; Kourí V; Alemán Y; Abrahantes Y; Correa C; Aragonés C; Martínez O; Pérez J; Fonseca C; Campos J; Álvarez D; Schrooten Y; Dekeersmaeker N; Imbrechts S; Beheydt G; Vinken L; Soto Y; Álvarez A; Vandamme AM; Van Laethem K
Infect Genet Evol; 2013 Jun; 16():144-50. PubMed ID: 23416260
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.
Grgic I; Lepej SZ; Lunar MM; Poljak M; Vince A; Vrakela IB; Planinic A; Seme K; Begovac J
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):329-36. PubMed ID: 22906365
[TBL] [Abstract][Full Text] [Related]
28. Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.
Medeiros MS; Arruda EA; Guerrant RL; Brown C; Hammarskjold ML; Rekosh D; Lima AA
Braz J Infect Dis; 2007 Aug; 11(4):390-4. PubMed ID: 17873990
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 infection among crack cocaine users in a region far from the epicenter of the HIV epidemic in Brazil: Prevalence and molecular characteristics.
França DDDS; Del-Rios NHA; Carneiro MADS; Guimarães RA; Caetano KAA; Reis MNDG; Martins RMB; Motta-Castro ARC; Stefani MMA; Teles SA
PLoS One; 2018; 13(7):e0199606. PubMed ID: 30016324
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
Yalçınkaya T; Köse S
Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
[TBL] [Abstract][Full Text] [Related]
31. Detection of human immunodeficiency virus Type 1 phylogenetic clusters with multidrug resistance mutations among 2011 to 2017 blood donors from the highly endemic Northern Brazilian Amazon.
Esashika Crispim MA; da Guarda Reis MN; Fraiji N; Bello G; Stefani MMA
Transfusion; 2019 Aug; 59(8):2593-2601. PubMed ID: 31119759
[TBL] [Abstract][Full Text] [Related]
32. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
[TBL] [Abstract][Full Text] [Related]
33. High resistance to reverse transcriptase inhibitors among persons infected with human immunodeficiency virus type 1 subtype circulating recombinant form 02_AG in Ghana and on antiretroviral therapy.
Deletsu SD; Maina EK; Quaye O; Ampofo WK; Awandare GA; Bonney EY
Medicine (Baltimore); 2020 Feb; 99(7):e18777. PubMed ID: 32049783
[TBL] [Abstract][Full Text] [Related]
34. Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006.
Ibe S; Hattori J; Fujisaki S; Shigemi U; Fujisaki S; Shimizu K; Nakamura K; Kazumi T; Yokomaku Y; Mamiya N; Hamaguchi M; Kaneda T
AIDS Res Hum Retroviruses; 2008 Jan; 24(1):7-14. PubMed ID: 18275342
[TBL] [Abstract][Full Text] [Related]
35. Frequency and diversity of human immunodeficiency virus type 1 mutations associated with antiretroviral resistance among patients from Southern Brazil failing highly active antiretroviral therapy (HAART).
Figueiredo Saad F; Kaminami Morimoto H; Wiechmann SL; Bonametti AM; Ueda LT; Matsuo T; Reiche EM
Int J Mol Med; 2010 Oct; 26(4):585-93. PubMed ID: 20818500
[TBL] [Abstract][Full Text] [Related]
36. Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy.
Santoro MM; Svicher V; Gori C; Zaccarelli M; Tozzi V; Forbici F; D'Arrigo R; Trotta MP; Bellocchi MC; Visco-Comandini U; Cenci A; Bertoli A; Narciso P; Antinori A; Perno CF; Ceccherini-Silberstein F
New Microbiol; 2006 Apr; 29(2):89-100. PubMed ID: 16841549
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.
Ibe S; Sugiura W
Future Microbiol; 2011 Mar; 6(3):295-315. PubMed ID: 21449841
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.
Sayan M; Sargin F; Inan D; Sevgi DY; Celikbas AK; Yasar K; Kaptan F; Kutlu S; Fisgin NT; Inci A; Ceran N; Karaoglan I; Cagatay A; Celen MK; Koruk ST; Ceylan B; Yildirmak T; Akalın H; Korten V; Willke A
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):26-31. PubMed ID: 26414663
[TBL] [Abstract][Full Text] [Related]
39. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated Indonesian patients.
Khairunisa SQ; Kotaki T; Witaningrum AM; Yunifiar M MQ; Sukartiningrum SD; Nasronudin ; Kameoka M
AIDS Res Hum Retroviruses; 2015 Feb; 31(2):255-9. PubMed ID: 25348045
[TBL] [Abstract][Full Text] [Related]
40. Geographic and temporal trends of transmitted HIV-1 drug resistance among antiretroviral-naïve subjects screening for two clinical trials in North America and Western Europe.
Rahim S; Fredrick LM; da Silva BA; Bernstein B; King MS
HIV Clin Trials; 2009; 10(2):94-103. PubMed ID: 19487179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
